Cardiac resynchronization therapy-heart failure (CRT-HF) clinic: A novel model of care

Eiran Z Gorodeski1, Christina Magnelli-Reyes2, Laurie Ann Moennich3

  • 1Section of Heart Failure and Cardiac Transplantation, Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.

Plos One
|September 20, 2019
PubMed

Insights

Post-implant care for heart failure (HF) patients receiving cardiac resynchronization therapy (CRT) needs a structured approach. A new multidisciplinary clinic model proved feasible, leading to frequent interventions for all patients.

Area of Science:

  • Cardiology
  • Medical Device Technology
  • Health Services Research

Background:

  • Current heart failure (HF) and cardiac resynchronization therapy (CRT) guidelines lack specific post-implant care protocols.
  • Fragmented care and poor inter-specialty communication hinder optimal outcomes for CRT patients.
  • A novel model for post-CRT care is needed for busy clinical settings.

Purpose of the Study:

  • To develop and evaluate a new, multidisciplinary model for post-implant care of patients undergoing cardiac resynchronization therapy (CRT).
  • To assess the feasibility and impact of a standardized, collaborative post-CRT care visit.

Main Methods:

  • A novel, multidisciplinary clinic was designed to standardize post-CRT care.
  • Patients received a one-time collaborative visit 6 months post-implant, including cardiac imaging, HF, and electrophysiology specialists.
  • Operational feasibility, patient characteristics, interventions, and new diagnoses were recorded.

Main Results:

  • 150 patients were seen, with 125 included in the analysis (CRT implanted for standard indications).
  • 95% of patients received interventions, with non-responders receiving more (median 3 vs. 2).
  • Interventions included device-related (26%), medication-related (74%), and referrals (80%).

Conclusions:

  • Multidisciplinary post-implant care for HF patients receiving CRT is feasible.
  • This care model leads to frequent medical interventions, irrespective of CRT response status.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
267
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
482
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
347
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
323
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
224
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416